Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9056777 | 0.71 | L3MBTL1 (0.31) | L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL6516407 | 0.67 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL396909 | 0.67 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL23845998 | 0.66 | — | — | |
| SCHEMBL28384679 | 0.66 | L3MBTL1 (0.46) | L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL28142318 | 0.66 | L3MBTL1 (0.46) | L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL5061242 | 0.65 | — | — | |
| SCHEMBL28773059 | 0.65 | — | — | |
| SCHEMBL27262316 | 0.64 | OPRM1 (0.32) | — | |
| SCHEMBL27262314 | 0.64 | OPRM1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996031217-A9 | INHIBITING RETROVIRAL REPLICATION | — | 1996-11-28 | — | — | WO | claimed |
| WO-1996002241-A9 | USE OF NITROGEN OXIDE SPECIES AND ADDUCTS TO INHIBIT SKELETAL MUSCLE CONTRACTION | — | 1996-02-29 | — | — | WO | claimed |
| WO-1996038136-A1 | LOCALIZED USE OF NITRIC OXIDE-ADDUCTS TO PREVENT INTERNAL TISSUE DAMAGE | NITROMED INC (US) | 1996-12-05 | — | — | WO | disclosed |
| WO-1996035416-A1 | LOCALIZED USE OF NITRIC OXIDEADDUCTS TO PREVENT INTERNAL TISSUE DAMAGE | NITROMED, INC. (US) | 1996-11-14 | — | — | WO | disclosed |